Stock analysts at Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Regeneron Pharmaceuticals in a ...

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...

Trump's "America First" ethos may come at a big cost to the stock market.

The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported ...

We recently published an article titled Jim Cramer’s Thoughts On These 8 Stocks and the Packaged Goods Playbook. In this ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

U.S. Capital Wealth Advisors LLC lifted its holdings in shares of Eastman Chemical (NYSE:EMN – Free Report) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the ...

Detailed price information for Jacobs Engineering Group Inc (J-N) from The Globe and Mail including charting and trades.

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic alternatives.” ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...